Anzeige
Mehr »
Montag, 06.10.2025 - Börsentäglich über 12.000 News
Das Paradox-Becken beweist seine Stärke - und American Critical Minerals sitzt direkt darauf
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A411DW | ISIN: CA81752F1062 | Ticker-Symbol: PSH0
Tradegate
06.10.25 | 18:52
0,114 Euro
-0,87 % -0,001
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
SERNOVA BIOTHERAPEUTICS INC Chart 1 Jahr
5-Tage-Chart
SERNOVA BIOTHERAPEUTICS INC 5-Tage-Chart
RealtimeGeldBriefZeit
0,1080,11619:48
0,1080,11418:52

Aktuelle News zur SERNOVA BIOTHERAPEUTICS Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
MiSernova Biotherapeutics Inc: Sernova converts debt of $13.3-million into units33
SERNOVA BIOTHERAPEUTICS Aktie jetzt für 0€ handeln
MiStocks in Play: Sernova Biotherapeutics25
MiSernova converts $13.3M debt to equity ahead of clinical milestone16
MiSernova Biotherapeutics Announces $13 Million Debt-to-Equity Conversion Eliminating Significant Financing Overhang216Toronto, Ontario and Boston, Massachusetts--(Newsfile Corp. - October 1, 2025) - Sernova Biotherapeutics (TSX: SVA) (OTCQB: SEOVF) (FSE: PSH0) ("Sernova") a leading regenerative medicine company focused...
► Artikel lesen
23.09.Sernova Biotherapeutics Inc: Sernova Biotherapeutics appoints Brooks chairman26
23.09.Sernova Corp.: Sernova Biotherapeutics Appoints John L. Brooks III, Former Chair and CEO of Joslin Diabetes Research Center, as Chair of the Board of Directors29
08.09.Sernova Corp.: Sernova Biotherapeutics to Participate in the H.C. Wainwright 27th Annual Global Investor Conference73
10.07.Sernova Biotherapeutics Inc: Sernova signs research deal with Eledon Pharma147
09.07.Sernova Biotherapeutics, Inc.: Sernova Biotherapeutics Announces Collaboration with Eledon Pharmaceuticals to Advance a Potential Functional Cure for Type 1 Diabetes1.073LONDON, Ontario, July 09, 2025 (GLOBE NEWSWIRE) -- Sernova Biotherapeutics ("Sernova") (TSX: SVA) (OTCQB: SEOVF) (FSE/XETRA: PSH) today announced a Collaborative Research Agreement with Eledon Pharmaceuticals...
► Artikel lesen
19.06.Research Capital analyst Andre Uddin keeps "Speculative Buy" rating on Sernova Biotherapeutics115
17.06.Sernova Biotherapeutics Inc: Sernova ex Haghighat pleads not guilty88
03.06.Sernova Biotherapeutics Inc: Sernova appoints Rigby as interim chair61
02.06.Sernova Biotherapeutics, Inc.: Sernova Appoints Jonathan Rigby as Interim Chair349LONDON, Ontario and BOSTON, June 02, 2025 (GLOBE NEWSWIRE) -- Sernova Biotherapeutics, (TSX: SVA) (OTCQB: SEOVF) (FSE/XETRA: PSH), a leading regenerative medicine company focused on developing its...
► Artikel lesen
02.06.Original-Research: Sernova Biotherapeutics Inc (von First Berlin Equity Research GmbH): Buy730Original-Research: Sernova Biotherapeutics Inc - from First Berlin Equity Research GmbH 02.06.2025 / 13:39 CET/CEST Dissemination of a Research, transmitted by EQS News - a service of EQS Group....
► Artikel lesen
26.05.Sernova Biotherapeutics Inc: Sernova chair Haghighat resigns52
26.05.Sernova Biotherapeutics says chair Ross Haghighat resigns24
26.05.Sernova Biotherapeutics Chair Ross Haghighat Resigns14
26.05.Sernova Biotherapeutics, Inc.: Chair of Sernova Biotherapeutics Resigns359LONDON, Ontario and BOSTON, May 26, 2025 (GLOBE NEWSWIRE) -- Sernova Biotherapeutics, (TSX: SVA) (OTCQB: SEOVF) (FSE/XETRA: PSH), a leading regenerative medicine company focused on developing its...
► Artikel lesen
24.05.Sernova Biotherapeutics Inc: Sernova's Haghighat charged for insider trading52
22.05.Sernova Biotherapeutics Inc: Sernova Biotherapeutics forms clinical advisory board16
Weiter >>
38 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,3,13